Jin Medical International Ltd. (ZJYL)
USD 0.61
(-4.21%)
USD 0.61
(-4.21%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.81 Million USD | 41.23% |
| 2022 | -4.79 Million USD | -30.51% |
| 2021 | -3.67 Million USD | -473.3% |
| 2020 | 983.72 Thousand USD | 5.79% |
| 2019 | 929.86 Thousand USD | 760.55% |
| 2018 | -140.77 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 985.93 Thousand USD | 135.01% |
| 2024 Q2 | 806.24 Thousand USD | 8.96% |
| 2023 Q4 | -2.81 Million USD | 0.0% |
| 2023 Q2 | -7.22 Million USD | 0.0% |
| 2023 Q3 | -2.81 Million USD | 61.03% |
| 2023 FY | -2.81 Million USD | 41.23% |
| 2023 Q1 | -7.22 Million USD | -50.82% |
| 2022 Q2 | -3.64 Million USD | 0.0% |
| 2022 FY | -4.79 Million USD | -30.51% |
| 2022 Q4 | -4.79 Million USD | 0.0% |
| 2022 Q3 | -4.79 Million USD | -31.59% |
| 2022 Q1 | -3.64 Million USD | 0.82% |
| 2021 Q2 | -3.25 Million USD | 0.0% |
| 2021 FY | -3.67 Million USD | -473.3% |
| 2021 Q3 | -3.67 Million USD | -12.67% |
| 2021 Q1 | -3.25 Million USD | -431.32% |
| 2021 Q4 | -3.67 Million USD | 0.0% |
| 2020 Q2 | 821.66 Thousand USD | 0.0% |
| 2020 Q1 | 821.66 Thousand USD | -11.64% |
| 2020 FY | 983.72 Thousand USD | 5.79% |
| 2020 Q4 | 983.72 Thousand USD | 0.0% |
| 2020 Q3 | 983.72 Thousand USD | 19.72% |
| 2019 Q4 | 929.86 Thousand USD | 0.0% |
| 2019 Q3 | 929.86 Thousand USD | 0.0% |
| 2019 Q1 | 2.45 Million USD | 0.0% |
| 2019 FY | 929.86 Thousand USD | 760.55% |
| 2018 FY | -140.77 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 209.125% |
| AngioDynamics, Inc. | -70.14 Million USD | 95.985% |
| AtriCure, Inc. | -9.81 Million USD | 71.307% |
| Avinger, Inc. | 10.12 Million USD | 127.831% |
| Azenta, Inc. | -618.47 Million USD | 99.545% |
| BioLife Solutions, Inc. | 7.25 Million USD | 138.832% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.115% |
| Daxor Corporation | 755.65 Thousand USD | 472.722% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -91.599% |
| Femasys Inc. | -15.01 Million USD | 81.242% |
| GlucoTrack, Inc. | -4.29 Million USD | 34.439% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 107.318% |
| Hologic, Inc. | 374.4 Million USD | 100.752% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.194% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.894% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 59.976% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 45.564% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 34.308% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 34.308% |
| Masimo Corporation | 804 Million USD | 100.35% |
| Microbot Medical Inc. | -2.28 Million USD | -23.207% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 70.648% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 100.932% |
| Nephros, Inc. | -2.47 Million USD | -13.983% |
| NovoCure Limited | 355.42 Million USD | 100.792% |
| NEXGEL, Inc. | 98 Thousand USD | 2973.988% |
| NEXGEL, Inc. | 98 Thousand USD | 2973.988% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 104.769% |
| OraSure Technologies, Inc. | -276.9 Million USD | 98.983% |
| Pro-Dex, Inc. | 10.91 Million USD | 125.802% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 92.003% |
| Predictive Oncology Inc. | -5.87 Million USD | 52.034% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 192.979% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.113% |
| Repligen Corporation | -39.51 Million USD | 92.873% |
| Sanara MedTech Inc. | 6.64 Million USD | 142.386% |
| STAAR Surgical Company | -147.2 Million USD | 98.087% |
| Sharps Technology, Inc. | -3.01 Million USD | 6.519% |
| Utah Medical Products, Inc. | -92.52 Million USD | 96.956% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.143% |